Clinical trial
Vildagliptin Versus Liraglutide - Patient Preference After Receiving Both Medications
NCT01518101
Study timeline
Study start (unknown)2012-01-01Date precision: month
Registry last updated2017-02-27
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Type 2 Diabetesunresolved
Interventions
LiraglutideDRUG · verified · RxNorm: liraglutide
MetforminDRUG · verified · RxNorm: metformin
Sponsors & collaborators
Novartis Pharmaceuticalslead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT01518101 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.